Q1 2023 Holdings
Filed 2023-05-15 | 121 holdings | $4.2B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Humana Inc(HUM) | COM | 444859102 | $207.0M | 426,500 | 4.9% |
| Agilon Health Inc(AGL) | COM | 00857U107 | $187.2M | 7,882,500 | 4.5% |
| Insulet Corp(PODD) | COM | 45784P101 | $171.2M | 536,750 | 4.1% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $148.4M | 3,001,662 | 3.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $130.4M | 350,000 | 3.1% |
| Unitedhealth Group Inc(UNH) | COM | 91324P102 | $127.6M | 270,000 | 3.0% |
| Evolent Health Inc(EVH) | CL A | 30050B101 | $123.4M | 3,803,500 | 2.9% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $122.5M | 1,210,100 | 2.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $120.8M | 433,500 | 2.9% |
| Prometheus Biosciences Inc | COM | 74349U108 | $110.7M | 1,031,550 | 2.6% |
| Idexx Labs Inc(IDXX) | COM | 45168D104 | $103.8M | 207,500 | 2.5% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $91.5M | 2,033,048 | 2.2% |
| Karuna Therapeutics Inc | COM | 48576A100 | $89.6M | 493,527 | 2.1% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $84.3M | 348,121 | 2.0% |
| Align Technology Inc(ALGN) | COM | 016255101 | $82.6M | 247,350 | 2.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $81.0M | 400,200 | 1.9% |
| Horizon Therapeutics PUB L | SHS | G46188101 | $80.8M | 740,100 | 1.9% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $76.3M | 298,500 | 1.8% |
| West Pharmaceutical Svsc Inc(WST) | COM | 955306105 | $70.0M | 202,000 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $69.1M | 345,000 | 1.6% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $63.8M | 941,500 | 1.5% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $62.2M | 860,868 | 1.5% |
| Cerevel Therapeutics Hldng I(CERE1EUR) | COM | 15678U128 | $61.3M | 2,513,916 | 1.5% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $61.1M | 2,661,605 | 1.5% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $61.0M | 442,500 | 1.5% |
| Dexcom Inc(DXCM) | COM | 252131107 | $57.0M | 490,500 | 1.4% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $55.6M | 1,454,254 | 1.3% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $53.6M | 1,336,401 | 1.3% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $53.4M | 645,900 | 1.3% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $45.6M | 425,500 | 1.1% |
| Freshpet Inc(FRPT) | COM | 358039105 | $43.9M | 662,500 | 1.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $43.1M | 1,795,733 | 1.0% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $42.6M | 1,452,816 | 1.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $42.2M | 1,178,002 | 1.0% |
| Pacira Biosciences Inc(PCRX) | COM | 695127100 | $42.1M | 1,032,600 | 1.0% |
| Phreesia Inc(PHR) | COM | 71944F106 | $42.1M | 1,302,500 | 1.0% |
| Biomea Fusion Inc(BMEA) | COM | 09077A106 | $40.2M | 1,297,213 | 1.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $39.6M | 1,065,261 | 0.9% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $39.0M | 1,077,900 | 0.9% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $38.4M | 309,450 | 0.9% |
| Olink Hldg AB | SPONSORED ADS | 680710100 | $37.2M | 1,650,000 | 0.9% |
| Accolade Inc(ACCDEUR) | COM | 00437E102 | $36.6M | 2,545,000 | 0.9% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $36.5M | 753,462 | 0.9% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $36.4M | 1,228,379 | 0.9% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $35.2M | 1,059,700 | 0.8% |
| Aclaris Therapeutics Inc(ACRS) | COM | 00461U105 | $32.1M | 3,961,849 | 0.8% |
| Abcam PLC | ADS | 000380204 | $30.2M | 2,242,500 | 0.7% |
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $28.7M | 1,276,650 | 0.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $28.5M | 1,597,123 | 0.7% |
| Select Sector Spdr TR(XLV) | SBI HEALTHCARE | 81369Y209 | $25.9M | 200,000 | 0.6% |